Ergoteles LLC Centogene N.V. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.3 - $5.44 $40,599 - $66,928	-12,303 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.56 - $10.56 $120,187 - $278,329	-26,357 Reduced 68.18%	12,303 $63,000
Q3 2021 Nov 15, 2021	SELL	$9.9 - $11.72 $2,376 - $2,812	-240 Reduced 0.62%	38,660 $426,000
Q2 2021 Aug 12, 2021	BUY	$9.02 - $12.93 $350,878 - $502,977	38,900 New	38,900 $406,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.